Invention Grant
- Patent Title: Antisense formulation
- Patent Title (中): 反义制剂
-
Application No.: US12996143Application Date: 2009-07-13
-
Publication No.: US08383336B2Publication Date: 2013-02-26
- Inventor: Thomas K. Hayes , Nicole D. Krilla , Lori Nixon
- Applicant: Thomas K. Hayes , Nicole D. Krilla , Lori Nixon
- Applicant Address: CA Vancouver
- Assignee: Oncogenex Technologies Inc.
- Current Assignee: Oncogenex Technologies Inc.
- Current Assignee Address: CA Vancouver
- Agency: Larson & Anderson, LLC
- International Application: PCT/US2009/050382 WO 20090713
- International Announcement: WO2010/009038 WO 20100121
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
A room temperature stable and minimal aggregate liquid formulation comprises an oligonucleotide comprising Seq ID No. 1: or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from Seq. ID NO. 1 and an aqueous carrier comprising a aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols.
Public/Granted literature
- US20110098343A1 Antisense Formulation Public/Granted day:2011-04-28
Information query
